Artivion (AORT) Cash from Operations Growth (3y) (2013 - 2026)
Artivion (AORT) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.27 Bn | 175.98 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.81 Bn | 125.93 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.63 Bn | 99.41 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.42 Bn | 66.96 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.84 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.31 Bn | 26.03 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.35 Bn | 2.07 Bn | 0.50% |
| 10 | Artivion | 1.26 Bn | 1.21 Bn | 75.45 Mn | 29.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.81% |
| Dec 31, 2025 | 351.66% |
| Sep 30, 2025 | 77.57% |
| Jun 30, 2025 | 56.12% |
| Mar 31, 2025 | -204.92% |
| Dec 31, 2024 | 141.93% |
| Sep 30, 2024 | 81.08% |
| Jun 30, 2024 | 32.34% |
| Mar 31, 2024 | -21.81% |
| Dec 31, 2023 | 25.75% |
| Sep 30, 2023 | -1.98% |
| Jun 30, 2023 | 59.20% |
| Mar 31, 2023 | -63.06% |
| Dec 31, 2022 | -30.15% |
| Sep 30, 2022 | -32.38% |
| Jun 30, 2022 | -136.00% |
| Mar 31, 2022 | -35.99% |
| Dec 31, 2021 | -59.17% |
| Sep 30, 2021 | -32.94% |
| Jun 30, 2021 | 51.12% |